From One Primary Care Physician to Another: Thank You
A small-town physician offers words of encouragement to his peers.
Daily Dose: Finerenone and Heart Failure Outcomes
Your daily dose of clinical news you may have missed.
Adult RSV Vaxx Gets EMA Nod: Can USA be Far Behind?
The GSK RSV vaccine candidate has received favorable international regulatory attention which may be an auspicious sign for the US.
Breast Cancer Rehab and Primary Care, with PM&R Specialist Sean Smith, MD
Breast cancer survivors rely on their primary care clinicians as resources integral to their recovery and return to optimal function. Physiatrist Sean Smith, MD, offers details.
Alcohol Use in America: By the Numbers
Which states have the most binge drinkers? Or the most alcohol-related deaths? A recent analysis provides answers.
Finerenone Mitigates HF, CV Risk Across Baseline Renal Function in Patients with T2D
The findings underscore the importance of routine eGFR and UACR screening in primary care to ensure early detection of CKD and avoid related adverse outcomes.
Low-carbohydrate Diet Could Help Improve Untreated HbA1c of 6.0% to 6.9%
In patients with prediabetes and untreated type 2 diabetes, a reduced carbohydrate diet improved HbA1c and other metabolic markers vs a usual diet.
Physicians Should Get Patients to Move More to Help with Cardiometabolic Health, Says One Expert
To help patients improve their cardiometabolic health, encourage them to move more, according to one speaker from CMHC 2022.
Daily Dose: Recombinant Zoster Vaccine Provides 10 Years of Protection
Daily Dose: High-dose Flu Vaccine Consistently More Effective vs Standard-dose
Recombinant Zoster Vaccine Protection Durable at 10 Years, New Study Finds
Efficacy of the RZV vaccine against herpes zoster infection remained >80% in a long-term follow-up study representing 10 years since initial immunization.
Cold & Flu Season 2022-23: AAFP Board Chair Shares Concerns
"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with American Academy of Family Physicians Board Chair Sterling Ransone, Jr, MD.
High- vs Standard-dose Dexamethasone Could Pose Risks for Ventilated COVID-19 Patients
High-dose dexamethasone is often prescribed for critically ill COVID-19 patients although there is no evidence for its efficacy. A new study looked deeper.
Daily Dose: Delay Before Start of Triple Therapy Raises Risk for COPD Exacerbations
Fluticasone Exhalation Delivery System Reduced Exacerbations, Need for Antibiotics in Patients with Chronic Sinusitis
IDWeek 2022: New data show a greater than 60% reduction in acute exacerbations and need for antibiotics in patients with CS who used fluticasone propionate nasal spray.
COVID-19 Vaccine Status Update: Adults, Bivalent Boosters, Kids, & Teens
The overall US COVID-19 vaccination picture has both bright spots and dark areas. Get a quick look at details from the most recent KFF Vaccine Monitor survey.
High-dose Influenza Vaccine Consistently More Effective vs Standard-dose in Older Adults: Meta-analysis
The high-dose influenza vaccines provided greater relative vaccine effectiveness/efficacy vs standard dose in a cohort of more than 45 million.
Daily Dose: Oral Superabsorbent Hydrogel Cuts Risk for Type 2 Diabetes
Real-world Study Suggests Need for Earlier Diagnosis of Non-alcoholic Steatohepatitis
CMHC 2022: Patients with NASH are often not diagnosed until an advanced stage, and have a high burden of comorbidities, according to new study.
COPD: Delay Before Start of Triple Therapy May Increase Risk for Exacerbations
CHEST. After a moderate COPD event, treatment with TT within 30 days significantly reduced risk for exacerbation over 12 months vs treatment after 30 days.
